Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb), Unsuitable or Suitable to Surgical Revascularization / Endovascular With Reference to the Change of Pain-free Walking Distance and Other Endpoints

Trial Profile

Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb), Unsuitable or Suitable to Surgical Revascularization / Endovascular With Reference to the Change of Pain-free Walking Distance and Other Endpoints

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2013

At a glance

  • Drugs Iloprost (Primary) ; Antiplatelets; Aspirin; HMG-CoA reductase inhibitors; Vasodilators
  • Indications Peripheral arterial disorders; Peripheral ischaemia; Thrombosis
  • Focus Therapeutic Use
  • Acronyms 2bPILOT
  • Most Recent Events

    • 07 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top